Zobrazeno 1 - 6
of 6
pro vyhledávání: '"PESI, pulmonary embolism severity index"'
Autor:
Hooman D. Poor
Publikováno v:
Chest
Coronavirus disease 2019 (COVID-19), the disease responsible for the devastating pandemic that began at the end of 2019, has been associated with a significantly increased risk of pulmonary thrombosis, even in patients receiving prophylactic anticoag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abc8de4607f598aa60deba9f3f2812e1
https://doi.org/10.1016/j.chest.2021.06.016
https://doi.org/10.1016/j.chest.2021.06.016
Autor:
Danielle T. Vlazny, David O. Hodge, Elias S. Saba, David A. Froehling, Lisa G. Peterson, Ana I. Casanegra, Hector R. Villarraga, Dalene M. Bott-Kitslaar, Waldemar E. Wysokinski, Robert D. McBane, Damon E. Houghton, Julia C. Cambron
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 4, Iss 3, Pp 249-258 (2020)
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 4, Iss 3, Pp 249-258 (2020)
Objective To determine whether the pulmonary embolism (PE) categories of massive, submassive, PE with no right ventricle dysfunction (NRVD), and subsegmental only (SSO) adequately predict clinical outcome. Methods Patients treated for acute PE (March
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c4df30f9202c5362c74b2a66fcd8e29
https://pubmed.ncbi.nlm.nih.gov/32542216
https://pubmed.ncbi.nlm.nih.gov/32542216
Publikováno v:
Indian Heart Journal
Indian Heart Journal, Vol 72, Iss 6, Pp 610-613 (2020)
Indian Heart Journal, Vol 72, Iss 6, Pp 610-613 (2020)
Right atrial volume/Left atrial volume (RAV/LAV) ratio is a good hemodynamic parameter in acute pulmonary thromboembolism (PTE), whose prognostic ability by 2D echocardiography is not studied to date. We conducted a 27 month, prospective observationa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1173c60393dc4055fa71f6e33367c3c9
https://pubmed.ncbi.nlm.nih.gov/33357655
https://pubmed.ncbi.nlm.nih.gov/33357655
Autor:
Zichen Xie, Hong-Lu Zhou, Chao Qiu, Jinyan Shao, Shuili Yu, Yang Li, Jianfeng Song, Keyu Sun, Xuan-Yi Wang
Publikováno v:
EClinicalMedicine
EClinicalMedicine, Vol 36, Iss, Pp 100897-(2021)
EClinicalMedicine, Vol 36, Iss, Pp 100897-(2021)
Background: Current prognostic scores for pulmonary embolism (PE) were partly based on patients without PE confirmation via computed tomographic pulmonary angiography (CTPA), involving subjective parameters and complicated scoring methods. Therefore,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2497908c589a68cd809a55c899b81c0e
https://doi.org/10.1016/j.eclinm.2021.100897
https://doi.org/10.1016/j.eclinm.2021.100897
Autor:
Yu S; Minhang Hospital and Institutes of Biomedical Sciences, Fudan University, Shanghai, China., Zhou H; Minhang Hospital and Institutes of Biomedical Sciences, Fudan University, Shanghai, China., Li Y; Minhang Hospital and Institutes of Biomedical Sciences, Fudan University, Shanghai, China., Song J; Minhang Hospital and Institutes of Biomedical Sciences, Fudan University, Shanghai, China., Shao J; Minhang Hospital and Institutes of Biomedical Sciences, Fudan University, Shanghai, China., Wang X; Minhang Hospital and Institutes of Biomedical Sciences, Fudan University, Shanghai, China., Xie Z; Minhang Hospital and Institutes of Biomedical Sciences, Fudan University, Shanghai, China., Qiu C; Minhang Hospital and Institutes of Biomedical Sciences, Fudan University, Shanghai, China., Sun K; Minhang Hospital and Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
Publikováno v:
EClinicalMedicine [EClinicalMedicine] 2021 May 31; Vol. 36, pp. 100897. Date of Electronic Publication: 2021 May 31 (Print Publication: 2021).
Autor:
Cambron JC; Mayo Clinic Alix School of Medicine, Mayo Clinic, Rochester, MN., Saba ES; Mayo Clinic Alix School of Medicine, Mayo Clinic, Rochester, MN., McBane RD; Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN., Casanegra AI; Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN., Villarraga HR; Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN., Houghton DE; Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN., Vlazny DT; Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN., Froehling D; Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN., Hodge D; Department of Health Sciences Research, Mayo Clinic, Jacksonville, FL., Peterson LG; Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN., Bott-Kitslaar DM; Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN., Wysokinski WE; Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN.
Publikováno v:
Mayo Clinic proceedings. Innovations, quality & outcomes [Mayo Clin Proc Innov Qual Outcomes] 2020 Jun 05; Vol. 4 (3), pp. 249-258. Date of Electronic Publication: 2020 Jun 05 (Print Publication: 2020).